Treatment, Clinical Outcomes, and Predictors of Mortality among a National Cohort of Admitted Patients with <i>Acinetobacter baumannii</i> Infection-Reference-Cited by-同舟云学术

Treatment, Clinical Outcomes, and Predictors of Mortality among a National Cohort of Admitted Patients with Acinetobacter baumannii Infection

Published:2022-03-15 Issue:3 Volume:66 Page:
ISSN:0066-4804
Container-title:Antimicrobial Agents and Chemotherapy
language:en
Short-container-title:Antimicrob Agents Chemother

Author:

Appaneal Haley J.¹²³^ORCID,Lopes Vrishali V.¹,LaPlante Kerry L.¹²³⁴^ORCID,Caffrey Aisling R.¹²³⁴^ORCID

Affiliation:

1. Infectious Diseases Research Program, Providence Veterans Affairs Medical Center, Providence, Rhode Island, USA

2. Center of Innovation in Long-Term Support Services, Providence Veterans Affairs Medical Center, Providence, Rhode Island, USA

3. College of Pharmacy, University of Rhode Island, Kingston, Rhode Island, USA

4. Warren Alpert Medical School of Brown University, Providence, Rhode Island, USA

Abstract

The objectives were to analyze treatment, clinical outcomes, and predictors of mortality in hospitalized patients with Acinetobacter baumannii infection. This was a retrospective cohort study of inpatients with A. baumannii cultures and treatment from 2010 to 2019.

Funder

Shionogi

Publisher

American Society for Microbiology

Subject

Infectious Diseases,Pharmacology (medical),Pharmacology

Link

https://journals.asm.org/doi/pdf/10.1128/aac.01975-21

Reference25 articles.

1. An emerging and important pathogen;Alsan M;J Clin Outcomes Manag,2010

2. Attributable mortality of Acinetobacter baumannii: no longer a controversial issue

3. Multidrug-resistantAcinetobacterInfection Mortality Rate and Length of Hospitalization